Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Detection of Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Exposed to Cisplatin-based Chemotherapy and Bone Marrow Transplant
Sponsor: Indiana University
Terminated
PI leaving Institution
Listed as NCT05611307, this observational or N/A phase trial focuses on ASCVD and Bone Marrow Transplant Complications and remains terminated or withdrawn. Sponsored by Indiana University, it has been updated 7 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Aug 2025 — Sep 2025 [monthly]
Recruiting
-
Mar 2025 — Aug 2025 [monthly]
Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
-
Dec 2022 — Jan 2024 [monthly]
Recruiting
First recorded
Oct 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Indiana University
- National Institutes of Health (NIH)
For direct contact, visit the study record on ClinicalTrials.gov .